BioXcel Therapeutics (BTAI) IPO Opens Flat

Today's IPO for BioXcel Therapeutics (NASDAQ: BTAI) opened for trading at $11.07 after pricing 5.5 million shares at $11.00.

Barclays, UBS Investment Bank and BMO Capital Markets were lead managers of the offering.

You May Also Be Interested In

• Sinda Ltd. prices IPO at $12 per share on NYSE
• JuNeng Technology files for IPO on Nasdaq at $4-$5 per share
• OpenAI Leans Toward Waiting Until Next Year For IPO - NYT